Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The HIV-LTR region contains binding sites for, and is regulated by, a number of transcription factors including Sp1 and NF-kB. The wild-type
p53 tumor suppressor protein
represses transcription from the HIV-LTR promoter while oncogenic mutant forms of
p53
stimulate expression from the HIV-LTR. We have shown previously that wild-type
p53
is a site specific DNA binding protein that binds to a region of the SV40 virus which contains GC-box DNA binding sites for the ubiquitously expressed transcription factor Sp1. In this study using
DNase I
footprinting, we have shown that purified
p53
is able to protect the Sp1 binding sites and the adjacent NF-kB site of the HIV-LTR. Furthermore we have demonstrated that when
p53
and Sp1 are mixed together both proteins change each other's interaction with DNA. Interestingly, we noted that oncogenic mutant p53 is also able to change the interaction of Sp1 with DNA. We confirmed
p53
dependent repression of HIV-LTR driven transcription by comparing the expression from an HIV-LTR reporter construct in the presence and absence of
p53
. EMSA of an oligonucleotide sequence derived from the HIV-LTR sequence demonstrated a slight decrease in Sp1 DNA binding activity with nuclear extract derived from the cell line expressing a high level of wild-type
p53
. These data suggest that the influence of
p53
on the transcription of promoters with Sp1 binding sites may be partially due to a change in the DNA binding ability of Sp1.
...
PMID:p53 represses Sp1 DNA binding and HIV-LTR directed transcription. 944 26
Myocyte apoptosis increases with age in Fischer 344 rats, but the multiple molecular events implicated in this phenomenon remain to be identified. Several defects involving Ca2+ homeostasis, pH, and the expression of
p53
and genes of the Bcl-2 protein family may contribute to the activation of myocyte death. Therefore, changes in intracellular pH, cytosolic Ca2+,
DNase I
and DNase II were measured in myocytes isolated by enzymatic digestion from rats of different ages. Moreover, the expression of
p53
, Bcl-2 and Bax in these cells was determined. Measurements of intracellular pH by BCECF fluorescence at 3, 12 and 24 months showed that this parameter did not change with age: 3 months, 7.20+/-0.05; 12 months, 7.21+/-0.07; 24 months, 7.18+/-0.09. In contrast, diastolic Ca2+ determined by the Fura 2-AM method increased progressively from 99.8+/-1.9 nm at 3 months to 136.3+/-9.6 nm at 24 months (P<0.001). Concurrently,
DNase I
activity evaluated by plasmid digestion assay in myocytes increased 3.2-fold from 3 to 24 months (P<0.02). Conversely, pH-dependent-DNase II remained essentially constant with age. Western blotting performed on ventricular myocytes did not detect significant changes in
p53
, Bax and Bcl-2 proteins with age. Similarly, immunocytochemically, the fraction of myocytes labeled by
p53
, Bax and Bcl-2 did not change from 3 to 24 months. In conclusion, myocyte aging is characterized by an increase in diastolic calcium which may activate
DNase I
triggering apoptosis, independently from the expression of
p53
, Bax and Bcl-2 in the cells.
...
PMID:Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats. 951 29
The mdm2 oncogene is a
p53
responsive gene which contains both a
p53
independent and a
p53
dependent promoter (P1 and P2 respectively). We have utilized ligation mediated PCR genomic footprinting in order to investigate the intra-nuclear binding of
p53
to the mdm2 P2 promoter. The
DNase I
protection pattern in nuclei from murine cells lacking
p53
has been compared to the protection pattern in cells containing a temperature sensitive
p53
-Val135. At 32 degrees C
p53
-Val135 assumes a wild-type conformation while at 37 degrees C this
p53
is conformationally mutant. We observed clear wild-type
p53
dependent protection of the putative
p53
response elements (REs) as well as protection of the adjacent TATA box. Interestingly the protection pattern observed with purified wild-type
p53
on naked DNA showed less nucleotide sequence protection than the protection observed to be
p53
dependent in nuclei. Constitutive
DNase I
hypersensitivity at both the mdm2 P1 and P2 promoters was detected by indirect Southern blot analysis.
DNase I
hypersensitivity reflects altered chromatin conformations resulting, most likely, from the absence of nucleosomes. Taken together our findings suggest that the mdm2 P2 promoter is maintained in a nucleosome free state which is pre-primed for transcriptional activation by
p53
.
...
PMID:p53 binds to a constitutively nucleosome free region of the mdm2 gene. 952 59
The adult rat liver is normally in a state of growth arrest. However, cell loss such as partial hepatectomy can induce the proliferation of the hepatocytes. Early after partial hepatectomy, the concentration of
p53 mRNA
increases during the prereplicative phase. In this study, we identified the cis-regulatory element involved in the induced transcription of the rat
p53
gene by
DNase I
footprinting assay. This element had a partial homology to the AP1 recognition motif, but the competition study with AP1 oligonucleotide showed that this element was not the AP1 recognition motif. The molecular weight of the binding protein to this motif was determined as 39 kDa by southwestern blotting analysis. In vitro transcription assay with the competitor containing the binding motif showed that the 39 kDa protein binding to the element was required for the induced transcription of the rat
p53
gene during the liver regeneration.
...
PMID:Transcription of the rat p53 gene is induced by a 39kDa protein binding to the p53 promoter region during the liver regeneration. 984 38
In this study we analyzed the ratp53 promoter by electrophoretic mobility shift assay (EMSA) and
DNase I
footprinting analysis. As a result we identified two protein binding elements (element 1: -296 to -312, element 2: -195 to -219) with sequence homology to each other. The two identified elements bind to the same kind of protein. To identify the protein binding to these elements, competition assays were carried out with double stranded oligonucleotides containing NF1, YY1, and CRE consensus motifs. Only the NF1 consensus motif competed with element 1 and 2. Element 2 is conserved between the rat, human, and mouse
p53
promoters, and has an NF1 consensus motif. However, the sequences of element 1 are comparatively variable between the species. Only the element 1 region of the rat
p53
promoter has partial homology to the NF1 consensus motif. This suggests that the element 1 is specific for the rat
p53
gene. The molecular mass of the binding protein, determined by Southwestern blotting analysis, was 40 kDa, which is different from that of NF1. In EMSA with an anti-NF1 antibody, DNA-protein complexes were neither supershifted nor decreased. The 40 kDa protein was also detected in rat spleen and lung, but not in kidney. The binding protein was purified by sequence-specific DNA affinity chromatography and it was confirmed that the purified protein binds to the two regions. It was also proved that the identified two elements are required for basal level transcription of the rat
p53
gene by in vitro transcription assay.
...
PMID:Transcription of the rat p53 gene is mediated by factor binding to two recognition motifs of NF1-like protein. 986 6
This report demonstrates that Gadd45, a
p53
-responsive stress protein, can facilitate topoisomerase relaxing and cleavage activity in the presence of core histones. A correlation between reduced expression of Gadd45 and increased resistance to topoisomerase I and topoisomerase II inhibitors in a variety of human cell lines was also found. Gadd45 could potentially mediate this effect by destabilizing histone-DNA interactions since it was found to interact directly with the four core histones. To evaluate this possibility, we investigated the effect of Gadd45 on preassembled mononucleosomes. Our data indicate that Gadd45 directly associates with mononucleosomes that have been altered by histone acetylation or UV radiation. This interaction resulted in increased
DNase I
accessibility on hyperacetylated mononucleosomes and substantial reduction of T4 endonuclease V accessibility to cyclobutane pyrimidine dimers on UV-irradiated mononucleosomes but not on naked DNA. Both histone acetylation and UV radiation are thought to destabilize the nucleosomal structure. Hence, these results imply that Gadd45 can recognize an altered chromatin state and modulate DNA accessibility to cellular proteins.
...
PMID:Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. 1002 55
The rat
p53
promoter has several potential transcription factor-recognition motifs. They include NF1-like, bHLH family, and AP1-like proteins binding sites. The binding protein to NF1-like motif was previously identified. The protein has about 40kDa of molecular mass, which is smaller than that of NF1. Anti-NF1 polyclonal antibody does not recognize the protein. In this study, we isolated the 40kDa protein by sequence-specific DNA affinity chromatography. The isolated protein was assayed by
DNase I
footprinting analysis. To determine the transactivation effect of the protein, in vitro transcription with the purified 40kDa protein was carried out. After the addition of the purified 40kDa protein into the transcription reaction mixture, the transcription level of the
p53
promoter was increased. This suggests that the 40 kDa NF1-like protein is a transcription activator for the rat
p53
gene.
...
PMID:In vitro transcription assay with the purified 40kDa NF1-like protein binding to the rat p53 promoter. 1020 79
A novel inhibitor of topoisomerases designated as topostatin was isolated from the culture filtrate of Thermomonospora alba strain No. 1520. The inhibitory activity of topostatin was shown to be pH- and temperature-dependent with a maximum around at pH 6 and 28 degrees C. The stability of topostatin decreased with decreasing pH and rising temperature. Topostatin inhibited topoisomerases I and II in a competitive manner with respect to DNA. The inhibitor also inhibited some restriction endonucleases such as Sca I, Hind III and Pst I, but not Alu I, Bam HI, Eco RI, RNase A,
DNase I
, DNase II and DNA ligase. Topostatin did not induce the nuclear accumulation of
p53 protein
by DNA damage in the normal human cells.
...
PMID:Topostatin, a novel inhibitor of topoisomerases I and II produced by Thermomonospora alba strain No. 1520. III. Inhibitory properties. 1048 May 69
GADD45 has been suggested to coordinate cell cycle regulation with the repair of DNA damage following ionizing radiation (IR). Although the GADD45 gene is transcriptionally up-regulated in response to IR, alterations in in vivo transcription factor (TF) binding or chromatin structure associated with up-regulation have not been defined. To understand how chromatin structure might influence TF binding and GADD45 up-regulation, key regulatory regions of the gene were identified by in vivo
DNase I
hypersensitivity (HS) analysis. Chromatin structure and in vivo TF binding in these regions were subsequently monitored in both non-irradiated and irradiated human ML-1 cells. In non-irradiated cells expressing basal levels of GADD45, the gene exhibited a highly organized chromatin structure with distinctly positioned nucleosomes. Also identified in non-irradiated cells were DNA-protein interactions at octamer binding motifs and a CCAAT box in the promoter and at consensus binding sites for AP-1 and
p53
within intron 3. Upon irradiation and a subsequent 15-fold increase in GADD45 mRNA levels, neither the chromatin structure nor the pattern of TF binding in key regulatory regions was altered. These results suggest that the GADD45 gene is poised for up-regulation and can be rapidly induced independent of gross changes in chromatin structure or TF binding.
...
PMID:Presetting of chromatin structure and transcription factor binding poise the human GADD45 gene for rapid transcriptional up-regulation. 1048 Oct 28
We provide direct evidence that overexpression of
p53
is not sufficient for robust
p53
-dependent activation of the endogenous gadd45 gene. When
p53
was induced in TR9-7 cells in the absence of DNA damage, waf1/p21 and mdm2 mRNA levels were increased, but a change in gadd45 mRNA was barely detectable. Activation of the gadd45 gene was observed when camptothecin was added to cells containing
p53
in the absence of a further increase in the
p53
level. Phosphorylation of
p53
at serine 15 and acetylation at lysine 382 were detected after drug treatment. It has been suggested that
p53
posttranslational modification is critical during activation. However, inhibition of these modifications by wortmannin was not sufficient to block the transactivation of gadd45. Interestingly, after camptothecin treatment, increased
DNase I
sensitivity was detected at the gadd45 promoter, suggesting that an undetermined DNA damage signal is involved in inducing chromatin remodeling at the gadd45 promoter while cooperating with
p53
to activate gadd45 transcription.
...
PMID:A DNA damage signal is required for p53 to activate gadd45. 1074 44
<< Previous
1
2
3
4
5
Next >>